Alar Pharmaceuticals Inc. (TPEX:6785)
Taiwan
· Delayed Price · Currency is TWD 184.50
-7.50 (-3.91%)
Mar 9, 2026, 1:30 PM CST
Alar Pharmaceuticals Revenue
Alar Pharmaceuticals had revenue of 1.25M TWD in the twelve months ending September 30, 2025, down -99.74% year-over-year. In the year 2024, Alar Pharmaceuticals had annual revenue of 5.82M, down -98.76%.
Revenue (ttm)
1.25M
Revenue Growth
-99.74%
P/S Ratio
9,836.07
Revenue / Employee
46.41K
Employees
27
Market Cap
12.32B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Foresee Pharmaceuticals | 519.61M |
| Handa Pharmaceuticals | 1.62B |
| Standard Chemical & Pharmaceutical | 7.02B |
| YungShin Global Holding | 8.37B |
| Synmosa Biopharma | 6.11B |
| ScinoPharm Taiwan | 3.16B |
| Grape King Bio | 10.25B |
| TTY Biopharm Company | 6.50B |